Inventor · disambiguated record
Rishi G. Vaswani
Also filed as: VASWANI RISHI G
23 granted patents·11 pending applications·177 citations·filing 2011–2023
95Inventor score
Files withCONSTELLATION PHARMACEUTICALS INC17FOGHORN THERAPEUTICS INC11RECLUDIX PHARMA INC3ALBRECHT BRIAN K2GENENTECH INC1
Top patents by PatentIndex Score
34 records- 0197US9469646B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Oct 18, 2016·21 cites·4 claims
- 0297US9249161B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2011·Granted Feb 2, 2016·50 cites·12 claims
- 0395US11497752B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2019·Granted Nov 15, 2022·7 cites·6 claims
- 0494US11485732B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Nov 1, 2022·8 cites·18 claims
- 0593US9085583B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION—PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·18 cites·14 claims
- 0692US12383560B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Granted Aug 12, 2025·1 cites·10 claims
- 0792US8796261B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2011·Granted Aug 5, 2014·21 cites·28 claims
- 0891US9371331B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Jun 21, 2016·8 cites·9 claims
- 0990US9624244B2Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Apr 18, 2017·8 cites·6 claims
- 1087US9745305B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·11 cites·17 claims
- 1187US9522920B2Bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Dec 20, 2016·10 cites·21 claims
- 1286US10016405B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jul 10, 2018·3 cites·4 claims
- 1385US9980952B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·3 cites·8 claims
- 1485US9969716B2Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted May 15, 2018·4 cites·21 claims
- 1580US10526287B2LSD1 inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jan 7, 2020·2 cites·22 claims
- 1679US12486262B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·0 cites·10 claims
- 1773US9925197B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·1 cites·5 claims
- 1872US9493483B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·1 cites·8 claims
- 1970US2023129003A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2069USRE47428EModulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·4 claims
- 2166US2019125737A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2264US2015376190A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2361US2025215030A1Stat modulators and uses thereofRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 2460US2025215029A1Stat modulators and uses thereofRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 2558US2025179103A16-oxodecahydropyrrolo[1,2-a][1,5]diazocine and 6-oxodecahydro-4h-pyrrolo[2,1-d][1,5]thiazocine derivatives as stat3 and stat6 modulators for the treatment of cancer and inflammatory conditionsRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 2655US2023149414A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2754US12509453B2BRM/BRG1 inhibitors and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Dec 30, 2025·0 cites·19 claims
- 2854US2023416248A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2953US2023121497A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3052US10457640B2Synthesis of inhibitors of EZH2CONSTELLATION PHARMACEUTICALS INC·Filed 2017·Granted Oct 29, 2019·0 cites·20 claims
- 3150US2023079819A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3248US12384776B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2020·Granted Aug 12, 2025·0 cites·17 claims
- 3341US10301253B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted May 28, 2019·0 cites·21 claims
- 3437US2018037568A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rishi G. Vaswani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →